首站-论文投稿智能助手
典型文献
Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study
文献摘要:
Asparaginase (Asp) represents a key agent in induction remission for acute lymphoblastic leukemia (ALL) and certain subtypes of non-Hodgkin lymphoma (NHL). By catalyzing the hydrolysis of extracellular asparagine, thus depleting the level of plasma asparagine necessary for the growth of leukemic lymphoblasts, Asp can inhibit leukemic lymphoblast protein synthesis and lead to subsequent apoptosis with little myelosuppression.[1] This will achieve anti-leukemia efficacy, and promote the remission of leukemia.[2] A previous study showed that an Asp-containing regimen could significantly increase the event-free survival rate (71% vs. 31%).[3] A previous study showed that those who completed the Asp regimen had a higher 5-year event-free survival rate (90%) than those who were unable to tolerate toxicity and quitted the treatment (73%).
文献关键词:
作者姓名:
Chen-xi Liu;Yun-yu Zhang;Qiu-shi Yang;Shu-hong Shen;Jing Chen;Yan-jing Tang;Chang-cheng Chen;Zhuo Wang;Bi-ru Li;Juan Qian;Ying Wang;Wen-ting Hu;Bo-tao Ning
作者机构:
Department of Pediatric Hematology and Oncology,Shanghai Children's Medical Center,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Department of Pediatric Intensive Care Unit,Shanghai Children's Medical Center,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China
引用格式:
[1]Chen-xi Liu;Yun-yu Zhang;Qiu-shi Yang;Shu-hong Shen;Jing Chen;Yan-jing Tang;Chang-cheng Chen;Zhuo Wang;Bi-ru Li;Juan Qian;Ying Wang;Wen-ting Hu;Bo-tao Ning-.Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study)[J].世界急诊医学杂志(英文),2022(04):313-321
A类:
Asparaginase,lymphoblasts,lymphoblast,quitted
B类:
associated,pancreatitis,chemotherapy,treated,pediatric,patients,five,year,retrospective,study,represents,key,agent,induction,remission,acute,lymphoblastic,leukemia,ALL,certain,subtypes,Hodgkin,lymphoma,NHL,By,catalyzing,hydrolysis,extracellular,asparagine,thus,depleting,level,plasma,necessary,growth,leukemic,inhibit,protein,synthesis,lead,subsequent,apoptosis,little,myelosuppression,This,will,achieve,anti,efficacy,promote,previous,showed,that,containing,regimen,could,significantly,increase,event,free,survival,those,who,completed,had,higher,than,were,unable,tolerate,toxicity,treatment
AB值:
0.610788
相似文献
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
Chunli Zhang;Wei Wan;Shuai Zhang;Jingwen Wang;Ru Feng;Jiangtao Li;Junyue Chai;Hebing Zhou;Liru Wang;Yuping Zhong;Xiaodong Mo;Mengzhu Shen;Hongmei Jing;Hui Liu-Department of Hematology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Hematology,Peking University Third Hospital,Beijing 100191,China;Department of Hematology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Department of Hematology,Beijing No.6 Hospital,Beijing 100007,China;Department of Hematology,Beijing Luhe Hospital,Capital Medical University,Beijing 101100,China;Department of Hematology,Fuxing Hospital,Capital Medical University,Beijing 100038,China;Department of Hematology,Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100043,China;Peking University People's Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,Beijing 100044,China
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Using a consensus acupoints regimen to explore the relationship between acupuncture sensation and lumbar spinal postoperative analgesia:A retrospective analysis of prospective clinical cooperation
Yen-Lin Chao;Yi-Ai Rau;Hong-Sheng Shiue;Jiun-Lin Yan;Yuan-Yun Tang;Shao-Wen Yu;Bo-Yan Yeh;Yen-Lung Chen;Tsung-Hsien Yang;Shu-Chen Cheng;Yi-Wen Hsieh;Hsin-Chia Huang;Fu-Kuang Tsai;Yu-Sheng Chen;Geng-Hao Liu-Division of Acupuncture and Moxibustion,Department of Traditional Chinese Medicine,Chang Gung Memorial Hospital,Taoyuan 333,Taiwan,China;School of Traditional Chinese Medicine,College of Medicine,Chang Gung University,Taoyuan 333,Taiwan,China;Department of Neurosurgery,Keelung Chang Gung Memorial Hospital,Keelung 204,Taiwan,China;Department of Traditional Chinese Medicine,New Taipei Municipal TuCheng Hospital,Chang Gung Memorial Hospital,New Taipei 236,Taiwan,China;Sleep Center,Chang Gung Memorial Hospital,Taoyuan 333,Taiwan,China
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Shen Junyi;Qi Weili;Dai Junlong;Leng Shusheng;Jiang Kangyi;Zhang Yu;Ran Shun;Li Chuan;Wen Tianfu-Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan 610072, China;Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan, Leshan, Sichuan 614700, China;Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chinese Academy of Sciences, Chengdu, Sichuan 610072, China;Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, China
Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph- high-risk B-cell acute lymphoblastic leukemia
Fan Menglin;Wang Yu;Lin Ren;Lin Tong;Huang Fen;Fan Zhiping;Xu Yajing;Yang Ting;Xu Na;Shi Pengcheng;Nie Danian;Lin Dongjun;Jiang Zujun;Wang Shunqing;Sun Jing;Huang Xiaojun;Liu Qifa;Xuan Li-Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing 100044, China;Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan 110051, China;Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510130, China;Department of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510630, China;Department of Hematology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, China;Department of Hematology, Guangzhou First People’s Hospital, Guangzhou, Guangdong 510080, China
Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission
Zhang Yongzhan;Bai Lu;Cheng Yifei;Lu Aidong;Wang Yu;Wu Jun;Zhang Xiaohui;Zuo Yingxi;Xu Lanping;Jia Yueping;Huang Xiaojun;Zhang Leping-Department of Pediatrics, Peking University People’s Hospital, Peking University, Beijing 100044, China;Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China;Department of Pediatrics, Peking University Shougang Hospital, Peking University, Beijing 100144, China;Department of Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China
Efficacy and safety of high-dose esomeprazole–amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
Bi Hanxin;Chen Xingxing;Chen Yuxin;Zhao Xin;Wang Shasha;Wang Jiehong;Lyu Ting;Han Shuang;Lin Tao;Li Mingquan;Yuan Donghong;Liu Junye;Shi Yongquan-Xi’an Medical University, Xi’an, Shaanxi 710021, China;State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital, Air Force Medical University, Xi’an, Shaanxi 710032, China;Department of Gastroenterology, Xianyang Central Hospital, Xianyang, Shaanxi 712000, China;Department of Gastroenterology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712000, China;Department of Gastroenterology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China;Department of Gastroenterology, Xi’an Red Cross Hospital, Xi’an, Shaanxi 710054, China;Department of Gastroenterology, Xi’an Daxing Hospital, Xi’an, Shaanxi 710082, China;Department of Gastroenterology, Yan’an People’s Hospital, Yan’an, Shaanxi 716000, China;Department of Gastroenterology, Yan’an University Affiliated Hospital, Yan’an, Shaanxi 716000, China;Department of Radiation Protective Medicine, Air Force Medical University, Xi’an, Shaanxi 710032, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。